Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Insilico Medicine to introduce 'Cure a disease in a year' program at Biodata World Congress 2018

Insilico Medicine to introduce 'Cure a disease in a year' program at Biodata World Congress 2018

UCLA biologists uncover how head injuries can lead to serious brain disorders

UCLA biologists uncover how head injuries can lead to serious brain disorders

Researchers produce 3D chemical maps of small biological samples

Researchers produce 3D chemical maps of small biological samples

Chapman University wins additional $2.9 million NIH grant to study Alzheimer's disease

Chapman University wins additional $2.9 million NIH grant to study Alzheimer's disease

Age-related decline in abstract reasoning ability predicts depressive symptoms over time

Age-related decline in abstract reasoning ability predicts depressive symptoms over time

Inhibition of one protein clears toxic clumps seen in Parkinson's disease, study finds

Inhibition of one protein clears toxic clumps seen in Parkinson's disease, study finds

Precision medicine-based approach to slow or reverse biologic drivers of Alzheimer's disease

Precision medicine-based approach to slow or reverse biologic drivers of Alzheimer's disease

Salk researchers report new methods to identify AD drug candidates with anti-aging properties

Salk researchers report new methods to identify AD drug candidates with anti-aging properties

Advanced AI and big data methods to tackle dementia

Advanced AI and big data methods to tackle dementia

Meditation, music may change biomarkers of cellular aging and Alzheimer’s disease in older adults

Meditation, music may change biomarkers of cellular aging and Alzheimer’s disease in older adults

Gladstone scientists gain new insights into the aging brain

Gladstone scientists gain new insights into the aging brain

Multidisciplinaryresearch teams selected to study age-related brain disorders

Multidisciplinaryresearch teams selected to study age-related brain disorders

Mild exposure to single blast can induce meaningful pathogenic effects, study shows

Mild exposure to single blast can induce meaningful pathogenic effects, study shows

Salk researchers receive $19.2 million to unravel mysteries of age-related cognitive decline

Salk researchers receive $19.2 million to unravel mysteries of age-related cognitive decline

Potential treatment for rare polio-like illness shows no signal of efficacy

Potential treatment for rare polio-like illness shows no signal of efficacy

Cardiovascular and Alzheimer's disease share common genetics in some individuals, study shows

Cardiovascular and Alzheimer's disease share common genetics in some individuals, study shows

Risk factors for dementia in veterans

Risk factors for dementia in veterans

AI could help spot Alzheimer’s early finds study

AI could help spot Alzheimer’s early finds study

Small molecules designed to inhibit activity of enzymes in infectious diseases

Small molecules designed to inhibit activity of enzymes in infectious diseases

Artificial intelligence technology improves prediction of Alzheimer’s disease

Artificial intelligence technology improves prediction of Alzheimer’s disease